Tim J Peterson, PharmD^1*, Andrew Lin, PharmD, BCOP^1*, Patrick Hilden, MS^2*, Sean Devlin, PhD^2*, Nelly G. Adel, PharmD, BCOP, BCPS^1* and Jae H Park, MD³

¹Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Gary J Schiller, MD¹, Lloyd E. Damon, MD^2*, Wendy Stock, MD³, Steven E Coutre, MD⁴, Pamela Hsu^5*, Lucy Prasad^5* and Dan Douer, MD⁶

¹University of California, Los Angeles, CA
²Department of Medicine, Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
³University of Chicago Medical Center, Chicago, IL
⁴Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
⁵spectrum pharmaceuticals, irvine
⁶Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

David S Shulman, MD^1*, Preeti Mehrotra, MD^2*, Neeraj K. Surana, MD, PhD^2*, Traci M. Blonquist, MS^3*, Lewis B. Silverman, MD⁴ and Andrew E. Place, MD, PhD⁵

¹Boston Children's Hospital, Boston, MA
²Division of Infectious Diseases, Boston Children's Hospital, Boston, MA
³Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA

Roel Polak, MD^1*, Marc B Bierings, MD PhD², Rob Pieters, MD, PhD^1,3, Miranda Buitenhuis, PhD^2* and Monique L. Den Boer, PhD¹

¹Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
²Department of Hematology and Immunology, Wilhelmina Children's Hospital, Utrecht, Netherlands
³Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Catriona Anne Parker, PhD^1*, Marie Reeves, MSc^1*, Sharon Love, MSc^2*, Jeremy Hancock, PhD^3*, Peter M Hoogerbrugge, MD, PhD⁴, Rosemary Sutton^5*, Tom Revesz, MD^6* and Vaskar Saha, PhD, FRCP, FRCPath^1,7,8

¹Children's Cancer Group, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom
²Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
³Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom
⁴Prinsess Máxima Center for Pediatric Oncology, De Bilt, Netherlands
⁵Molecular Diagnostics, Children’s Cancer Institute Australia, Sydney, Australia
⁶Clinical Haematology/Oncology, Children, Youth & Women's Health Service, Adelaide, Australia
⁷Tata Translational Cancer Research Centre, Kolkata, India
⁸Tata Medical Center, Kolkata, India

Koji Sasaki, MD¹, Paul B. Koller, MD², Hagop M. Kantarjian, MD³, Deborah A Thomas, MD³, Maria R. Khouri^4*, Guillermo Garcia-Manero, MD³, Rebecca Garris^3*, Jorge E. Cortes, MD³, Heather Schroeder^3*, Jad Chahoud, MD⁵, Tapan Kadia, MD³, Farhad Ravandi, MD³, Srdan Verstovsek, MD, PhD³, Naval Daver, MD³, Nitin Jain, MD³, Marina Konopleva, MD, PhD⁶, Susan O'Brien, MD³ and Elias Jabbour³

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵University of Texas Hosuton Health Science Center, Houston, TX
⁶Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Bruce Bostrom, MD¹, Bhoopatiraju Sweta^2* and S. Jill James, Ph.D.^3*

¹Pediatric Oncology, Children's Hospitals & Clinics of Minnesota, Minneapolis, MN
²Children's Hospitals and Clinics of Minnesota, Minneapolis, MN
³Research Institute, Arkansas Children’s Hospital, Little Rock, AR

Bob de Rooij, MSc^1*, Roel Polak, MD^1*, Rob Pieters, MD, PhD² and Monique L. Den Boer, PhD¹

¹Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
²Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Jad Chahoud, MD¹, Hagop M. Kantarjian, MD², Guillermo Garcia-Manero, MD², Koji Sasaki, MD², Tapan Kadia, MD², Jorge E. Cortes, MD², Maria R. Khouri^3*, Farhad Ravandi, MD², Jenny Dahl, PA^4*, Alessandra Ferrajoli, MD², Jovitta Jacob, RN^2*, Naveen Pemmaraju, MD², Naval Daver, MD², Rebecca Garris^2* and Elias Jabbour²

¹University of Texas Hosuton Health Science Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Hesham Eissa, MD¹, Yinmei Zhou, MS^2*, John C Panetta, PhD^3*, Emily Browne, RN, MSN, CPNP^4*, Sima Jeha, MD¹, Dario Campana, MD, PhD^1,5, William E. Evans, PharmD³, Ching-Hon Pui, MD¹, Mary V. Relling, PharmD³ and Hiroto Inaba, MD, PhD¹

¹Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
²Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
³Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN
⁴Department of Nursing Research, St Jude Children's Research Hospital, Memphis, TN
⁵Department of Pediatrics, National University of Singapore, Singapore, Singapore

Zheng Ge, MD, PhD, Min Li, MD^*, Lichan Xiao, MD^*, Run Zhang, MD^* and Jianyong Li, MD, PhD

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Bingcheng Liu, MD^*, Ying Wang, MD^*, Chunlin Zhou, MD, PhD^*, Hui Wei, MD, PhD^*, Dong Lin, MD, PhD^*, Wei Li, MD^*, Kaiqi Liu^*, Guangji Zhang^*, Shuning Wei^*, Yan Li, MD^*, Benfa Gong^*, Yuntao Liu^*, Yingchang Mi, MD, PhD and Jianxiang Wang, MD

Chinese Academy of Medical Sciences & Peking Union Medical College,Hospital of Blood Diseases, Tianjin, China

Guopan Yu^1*, Dan Xu^1*, Qifa Liu, MD², Jing Sun, MD², Zhiping Fan^1*, Qiang Wang^1*, Xiaoli Liu^1* and Qianli Jiang, MD, PhD^2*

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China

Wanda Salzer, MD¹, Michael J. Burke, MD^2,3, Eric C. Larsen, MD^4*, Si Chen, MS^5*, Lia Gore, MD⁶, Joanne M. Hilden, MD⁶, Mignon L. Loh, MD⁷, Elizabeth Raetz, MD⁸, Naomi J. Winick, MD⁹, William L. Carroll, MD¹⁰, Meenakshi Devidas, PhD⁵ and Stephen P Hunger, MD¹¹

¹U.S. Army Medical Research and Materiel Command, Fort Detrick, MD
²Division of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI
³Children's Hospital of Wisconsin, Milwaukee, WI
⁴Maine Children's Cancer Program, Scarborough, ME
⁵Department of Biostatistics, Colleges of Medicine, Public Health & Health Profession, University of Florida, Gainesville, FL
⁶Center for Cancer and Blood Disorders, Children's Hospital Colorado and the University of Colorado School of Medicine, Aurora, CO
⁷Department of Pediatrics, Benioff Children’s Hospital, University of California at San Francisco, San Francisco, CA
⁸Department of Pediatrics, Huntsman Cancer Institute and Primary Children's Hospital, University of Utah, Salt Lake City, UT
⁹University of Texas Southwestern Medical Center, Dallas, TX
¹⁰Department of Pediatrics, Perlmutter Cancer Center,, New York University Medical Center, New York, NY
¹¹Department of Pediatrics, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Ofir Wolach, MD^1*, Kristen Stevenson, MS^2*, Martha Wadleigh, MD¹, Daniel J. DeAngelo, MD, PhD¹, David P. Steensma, MD¹, Robert J. Soiffer, MD¹, Joseph H Antin, MD¹, Donna S Neuberg, ScD², Vincent T. Ho, MD¹ and Richard M. Stone, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA

Aaron S Rosenberg, MD, MS¹, Ann M Brunson, BS^2*, Theresa HM Keegan, PhD, MSc^2*, Joseph Tuscano, MD³, Ted Wun, MD⁴ and Brian Jonas, MD, PhD⁵

¹Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
²University of California, Davis, Sacramento, CA
³University of California Davis, Sacramento, CA
⁴Division of Hematology and Oncology, University of California – Davis School of Medicine, Sacramento, CA
⁵UC Davis Comprehensive Cancer Center, Sacramento, CA